DENDREON TARGETING CANCER, TRANSFORMING LIVES Trademark

Trademark Overview

On Friday, October 14, 2005, a trademark application was filed for DENDREON TARGETING CANCER, TRANSFORMING LIVES with the United States Patent and Trademark Office. The USPTO has given the DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark a serial number of 78733533. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 26, 2018. This trademark is owned by Dendreon Corporation. The DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of cancer and autoimmune and infectious diseases
dendreon targeting cancer, transforming lives

General Information

Serial Number78733533
Word MarkDENDREON TARGETING CANCER, TRANSFORMING LIVES
Filing DateFriday, October 14, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 26, 2018
Registration Number3982430
Registration DateTuesday, June 21, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 14, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"CANCER"
Goods and ServicesPharmaceuticals for use in the treatment of cancer and autoimmune and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 26, 2018
Primary Code005
First Use Anywhere DateThursday, April 29, 2010
First Use In Commerce DateThursday, April 29, 2010

Trademark Owner History

Party NameDENDREON PHARMACEUTICALS LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameDENDREON PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBRIDGEWATER, NJ 08807
Party NameDendreon Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameDendreon Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameDendreon Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Friday, January 26, 2018CANCELLED SEC. 8 (6-YR)
Friday, April 21, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 21, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 22, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, April 22, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 19, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 21, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 29, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 15, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 20, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 20, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 5, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 21, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, May 18, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 17, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, May 13, 2011ASSIGNED TO LIE
Thursday, April 28, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 27, 2011STATEMENT OF USE PROCESSING COMPLETE
Monday, April 25, 2011USE AMENDMENT FILED
Monday, April 25, 2011TEAS STATEMENT OF USE RECEIVED
Saturday, September 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 24, 2010EXTENSION 5 GRANTED
Tuesday, September 21, 2010EXTENSION 5 FILED
Tuesday, September 21, 2010TEAS EXTENSION RECEIVED
Tuesday, May 11, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 10, 2010EXTENSION 4 GRANTED
Wednesday, May 5, 2010EXTENSION 4 FILED
Wednesday, May 5, 2010TEAS EXTENSION RECEIVED
Tuesday, January 5, 2010ASSIGNED TO EXAMINER
Friday, October 2, 2009EXTENSION 3 GRANTED
Monday, September 28, 2009EXTENSION 3 FILED
Monday, September 28, 2009TEAS EXTENSION RECEIVED
Thursday, July 23, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 21, 2009PAPER RECEIVED
Friday, May 29, 2009EXTENSION 2 GRANTED
Friday, May 22, 2009EXTENSION 2 FILED
Friday, May 22, 2009TEAS EXTENSION RECEIVED
Friday, December 12, 2008EXTENSION 1 GRANTED
Wednesday, December 3, 2008EXTENSION 1 FILED
Friday, December 12, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 3, 2008TEAS EXTENSION RECEIVED
Tuesday, June 3, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 22, 2008TTAB RELEASE CASE TO TRADEMARKS
Tuesday, April 22, 2008OPPOSITION TERMINATED NO. 999999
Tuesday, April 22, 2008OPPOSITION DISMISSED NO. 999999
Thursday, May 25, 2006OPPOSITION INSTITUTED NO. 999999
Monday, April 3, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 14, 2006PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2006NOTICE OF PUBLICATION
Thursday, January 26, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 20, 2006ASSIGNED TO LIE
Friday, January 13, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 13, 2006EXAMINER'S AMENDMENT ENTERED
Friday, January 13, 2006EXAMINERS AMENDMENT E-MAILED
Friday, January 13, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 4, 2006ASSIGNED TO EXAMINER
Thursday, October 20, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

lives transforming cancer targeting dendreon infectious diseases autoimmune treatment pharmaceuticals